Resultados de procura - Shamir R. Mehta
- Mostrando 1 - 20 Resultados de 70
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation por Salim Yusuf, Shamir R. Mehta, Changchun Xie, Rashid Ahmed, Denis Xavier, Prem Pais, Jun Zhu, Lisheng Liu
Publicado 2005Artigo -
7
-
8
-
9
-
10
Incidence of thrombosis in perioperative and non-operative myocardial infarction por Tej Sheth, Madhu K. Natarajan, Victar Hsieh, Nicholas Valettas, Michael Rokoss, Shamir R. Mehta, Sanjit S. Jolly, Vikas Tandon, Hiram G. Bezerra, P.J. Devereaux
Publicado 2017Artigo -
11
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction por Kevin R. Bainey, Thomas Engstrøm, Pieter C. Smits, Anthony Gershlick, Stefan James, Robert F. Storey, David Wood, Roxana Mehran, John A. Cairns, Shamir R. Mehta
Publicado 2020Revisão -
12
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes por Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Díaz, Patrick Commerford, Vicent Valentín, Salim Yusuf
Publicado 2003Artigo -
13
-
14
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials por Subodh Verma, Shaun G. Goodman, Shamir R. Mehta, David A. Latter, Marc Ruel, Milan Gupta, Bobby Yanagawa, Mohammed Al‐Omran, Nandini Gupta, Hwee Teoh, Jan O. Friedrich
Publicado 2015Revisão -
15
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrom... por Philippe Gabríel Steg, Shamir R. Mehta, J. Wouter Jukema, Gregory Y.H. Lip, C. Michael Gibson, František Kovář, Petr Kala, Alberto García-Hernández, Ronny Renfurm, Christopher B. Granger
Publicado 2011Artigo -
16
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes por Salim Yusuf, Shamir R Mehta, Susan Chrolavicius, Rizwan Afzal, Janice Pogue, Christopher B. Granger, Andrzej Budaj, Ron Peters, Jean‐Pierre Bassand, Lars Wallentin, Campbell Joyner, Keith A.A. Fox
Publicado 2006Artigo -
17
Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial por Salim Yusuf, Shamir R. Mehta, Susan Chrolavicius, Rizwan Afzal, Janice Pogue, Christopher B. Granger, Andrzej Budaj, Ron Peters, Jean‐Pierre Bassand, Lars Wallentin, Campbell Joyner, Keith A.A. Fox
Publicado 2006Artigo -
18
Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes por Shaheen Pandie, Shamir R. Mehta, Warren J. Cantor, Asim N. Cheema, Peggy Gao, Mina Madan, Kari Niemelä, Sunil V. Rao, Jon David Schwalm, Vicent Valentín, James L. Velianou, Sanjit S. Jolly
Publicado 2015Artigo -
19
Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy por Jean‐François Tanguay, Alan Bell, Margaret L. Ackman, Douglas C. Bauer, Raymond Cartier, Wee‐Shian Chan, James D. Douketis, André Roussin, Gregory Schnell, Subodh Verma, Graham C. Wong, Shamir R. Mehta
Publicado 2013Revisão -
20
Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies por Darryl P. Leong, Filipe Cirne, Nazanin Aghel, Rocío Consuelo Baro Vila, Germano Dallegrave Cavalli, Peter Ellis, Jeff S. Healey, Richard Whitlock, Dina Khalaf, Hira Mian, Sanjit S. Jolly, Shamir R. Mehta, Susan Dent
Publicado 2023Revisão
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Cardiology
Myocardial infarction
Percutaneous coronary intervention
Acute coronary syndrome
Confidence interval
Randomized controlled trial
Conventional PCI
Surgery
Aspirin
Hazard ratio
Clopidogrel
Pathology
Alternative medicine
Anesthesia
Placebo
Engineering
Mechanical engineering
Stroke (engine)
Revascularization
Ticagrelor
Intensive care medicine
Antithrombotic
Heparin
Psychiatry
Thrombosis
Culprit
Environmental health
Population